Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Oncothyreon (ONTY) Data Known, Shares May React to Puma (PBYI) Release, Says Cantor
-
Immunogen (IMGN) ASCO Data on IMGN853 'Solidifies' Pipeline Potential, Cantor Fitzgerald Says
-
Cisco (CSCO) PT Boosted to $36 at Cantor Fitzgerald Amid Strong Quarter
-
Avino Announces Proceeds to Date From the At-The-Market Offering
-
Cantor Fitzgerald Raises Price Target on Phibro Animal Health (PAHC) Based on Growth Prospects
-
Cantor Fitzgerald Reiterate Hold Following Ligand Pharma's (LGND) Strong Q1
-
Cantor Fitzgerald Downgrades AOL, Inc. (AOL) to Sell; Deal Positive for Yahoo! (YHOO)
-
NewLink Genetics (NLNK) Weakness Offers Opportunity, Cantor Fitzgerald Says
-
Cantor Fitzgerald Loweres PT Despite BioDelivery Sciences' (BDSI) Earnings Beat
-
Orchid Island Capital Announces May 2015 Monthly Dividend and April 30, 2015 RMBS Portfolio Characteristics
-
Orchid Island Capital Announces May 2015 Monthly Dividend and April 30, 2015 RMBS Portfolio Characteristics
-
Synergy Pharmaceuticals Reports 2015 First Quarter Results and Business Update
-
Cantor Fitzgerald Starts Paratek Pharmaceuticals (PRTK) at Buy
-
New Book Explores Country's Modern Monetary System, Federal Spending
-
Cantor Fitzgerald Loweres PT to $165 for Jazz Pharmaceuticals (JAZZ) Following 1Q15 EPS Miss
-
Cantor Fitzgerald Retains Bullish Views for AOL (AOL) Following Results
-
Tableau Software (DATA) PT Lifted to $158 at Cantor Fitzgerald Amid 'Strong' Q1
-
Cantor Fitzgerald Upgrades Aerie Pharma (AERI) to Buy
-
Merrimack Pharmaceuticals Reports First Quarter 2015 Financial Results
-
EU Patent Action Removes Overhang on Celgene (CELG), Cantor Fitzgerald Says
-
Apple (AAPL) Sees Upside Ahead of Icahn Update
-
Cantor Fitzgerald Maintains Bullish View on The Priceline Group (PCLN) Following 'Strong' Q1
-
UPDATE: Cantor Fitzgerald Downgrades Sucampo Pharmaceuticals (SCMP) to Hold
-
Cantor Fitzgerald Starts Big Lots (BIG) at Hold
-
Fitch Upgrades GFI to 'BB+', Outlook Positive; Affirms BGC & Cantor Fitzgerald at 'BBB-'
-
Flex Pharma Reports First Quarter 2015 Financial Results
-
TransEnterix, Inc. Reports Operating Results for the First Quarter 2015
-
Canaccord Genuity Expands Global REIT Capability with Addition of Dedicated Banking, Equity Research and Sales Professionals in New York and San Francisco
-
UPDATE - MarketCounsel Hires Veteran RIA Industry Executives Loren Morris and Bob Powell
-
Paratek Announces Closing of Common Stock Offering
-
MarketCounsel Hires Veteran RIA Industry Executives Loren Morris and Bob Powell
-
Sunesis Pharmaceuticals Reports First Quarter 2015 Financial Results and Recent Highlights
-
Cantor Fitzgerald Maintains Bullish Views Following Cisco (CSCO) Leadership Change
-
FiComm Partners Adds Chris Latham and Dana Mahoney as Newest Team Members; Enhances Content Development and Marketing Support Offerings
-
Cantor Fitzgerald Maintains Positive Outlook for Alibaba (BABA) Ahead of Q1 Despite Monetization Headwinds
-
Cantor Fitzgerald Maintains Bullish View on The Priceline Group (PCLN) Ahead of Q1 Results
-
Cantor Fitzgerald Sees In-Line to Better Results from Shutterstock (SSTK)
-
Cantor Fitzgerald Maintains Bullish View comScore (SCOR) Ahead of Q1 Print
-
Durect (DRRX) PT Lifted to $3 at Cantor Fitzgerald on Solid Q1 and Multiple Catalysts
-
LinkedIn (LNKD) PT Cut to $245 at Cantor Fitzgerald; 'Buy' Maintained
-
Expedia (EXPE) Price Target Raised to $110 at Cantor Fitzgerald on Solid Core Results
-
Celldex (CLDX) Bullish Stance Reiterated at Cantor Fitzgerald Following Q1 and Update
-
Cantor Fitzgerald Starts L Brands (LB) at Hold
-
Cantor Fitzgerald Wealth Partners Continues Rapid Expansion with First Wirehouse Team
-
Valeant Pharmaceuticals (VRX) PT Lifted to $271 at Cantor Fitzgerald
-
Paratek Announces Pricing of Public Offering of 2,860,000 Shares of Common Stock
-
Lack of Short-Term Visibility at Twitter (TWTR) But Long-Term Intact, Cantor Fitzgerald Says; PT to $50
-
Apple (AAPL) PT Raised to 'Street High' $195 at Cantor Fitzgerald
-
Profile Technologies (PRTK) Commences $60M Common Stock Offering
-
Orchid Island Capital Announces First Quarter 2015 Results

